{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:36:09Z","timestamp":1785270969752,"version":"3.55.0"},"reference-count":31,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.3892\/or.2014.3134","type":"journal-article","created":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T08:15:26Z","timestamp":1397204126000},"page":"2804-2810","source":"Crossref","is-referenced-by-count":10,"title":["Rapamycin inhibits Toll-like receptor 4-induced pro-oncogenic function in head and neck squamous cell carcinoma"],"prefix":"10.3892","volume":"31","author":[{"given":"GUOXIN","family":"REN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JINGZHOU","family":"HU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RUNXIANG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEI","family":"HAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MEI","family":"ZHAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GE","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHENPING","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHIYUAN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,4,11]]},"reference":[{"key":"key20180107223030_b1-or-31-06-2804","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms","volume":"13","author":"Elinav","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"key20180107223030_b2-or-31-06-2804","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1158\/1078-0432.CCR-12-0408","article-title":"Molecular pathways: toll-like receptors in the tumor microenvironment - poor prognosis or new therapeutic opportunity","volume":"19","author":"Ridnour","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key20180107223030_b3-or-31-06-2804","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"key20180107223030_b4-or-31-06-2804","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2006.02.016","article-title":"Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer","volume":"124","author":"Karin","year":"2006","journal-title":"Cell"},{"key":"key20180107223030_b5-or-31-06-2804","first-page":"765","article-title":"Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer","author":"Belmont","year":"2013","journal-title":"Int J Cancer"},{"key":"key20180107223030_b6-or-31-06-2804","doi-asserted-by":"crossref","first-page":"e25238","DOI":"10.4161\/onci.25238","article-title":"Trial Watch: Toll-like receptor agonists for cancer therapy","volume":"2","author":"Vacchelli","year":"2013","journal-title":"Oncoimmunology"},{"key":"key20180107223030_b7-or-31-06-2804","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1172\/JCI59889","article-title":"The molecular pathogenesis of head and neck squamous cell carcinoma","volume":"122","author":"Rothenberg","year":"2012","journal-title":"J Clin Invest"},{"key":"key20180107223030_b8-or-31-06-2804","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180107223030_b9-or-31-06-2804","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"key":"key20180107223030_b10-or-31-06-2804","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1158\/0008-5472.CAN-07-1756","article-title":"A retroinhibition approach reveals a tumor cell-autonomous response to rapamycin in head and neck cancer","volume":"68","author":"Amornphimoltham","year":"2008","journal-title":"Cancer Res"},{"key":"key20180107223030_b11-or-31-06-2804","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1158\/0008-5472.CAN-08-3838","article-title":"Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack","volume":"69","author":"Szczepanski","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107223030_b12-or-31-06-2804","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1535-6108(04)00090-X","article-title":"Focus on head and neck cancer","volume":"5","author":"Mao","year":"2004","journal-title":"Cancer Cell"},{"key":"key20180107223030_b13-or-31-06-2804","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1038\/sj.onc.1209886","article-title":"mTOR and cancer therapy","volume":"25","author":"Easton","year":"2006","journal-title":"Oncogene"},{"key":"key20180107223030_b14-or-31-06-2804","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrd2062","article-title":"Current development of mTOR inhibitors as anticancer agents","volume":"5","author":"Faivre","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107223030_b15-or-31-06-2804","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1200\/JCO.2008.16.2347","article-title":"Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumors","volume":"26","author":"Jimeno","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107223030_b16-or-31-06-2804","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.dld.2012.02.005","article-title":"Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma","volume":"44","author":"Decaens","year":"2012","journal-title":"Dig Liver Dis"},{"key":"key20180107223030_b17-or-31-06-2804","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4161\/cbt.2.3.360","article-title":"Rapamycins: mechanism of action and cellular resistance","volume":"2","author":"Huang","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"key20180107223030_b18-or-31-06-2804","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1158\/1078-0432.CCR-07-1041","article-title":"Dissecting the Akt\/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative","volume":"13","author":"Molinolo","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107223030_b19-or-31-06-2804","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.ejca.2007.08.016","article-title":"Molecular targeted therapy of head and neck cancer: review and clinical development challenges","volume":"43","author":"Le Tourneau","year":"2007","journal-title":"Eur J Cancer"},{"key":"key20180107223030_b20-or-31-06-2804","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cncr.23996","article-title":"Critical and diverse involvement of Akt\/mammalian target of rapamycin signaling in human lung carcinomas","volume":"115","author":"Dobashi","year":"2009","journal-title":"Cancer"},{"key":"key20180107223030_b21-or-31-06-2804","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1016\/j.molimm.2008.01.025","article-title":"Rapamycin suppresses TLR4-triggered IL-6 and PGE(2) production of colon cancer cells by inhibiting TLR4 expression and NF-kappaB activation","volume":"45","author":"Sun","year":"2008","journal-title":"Mol Immunol"},{"key":"key20180107223030_b22-or-31-06-2804","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1099\/jmm.0.47352-0","article-title":"Intra-individual diversity and similarity of salivary and faecal microbiota","volume":"57","author":"Maukonen","year":"2008","journal-title":"J Med Microbiol"},{"key":"key20180107223030_b23-or-31-06-2804","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1158\/1078-0432.CCR-07-0666","article-title":"Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue","volume":"14","author":"Wong","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107223030_b24-or-31-06-2804","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1476-4598-11-33","article-title":"Role of toll-like receptor 4 on the immune escape of human oral squamous cell carcinoma and resistance of cisplatin-induced apoptosis","volume":"11","author":"Sun","year":"2012","journal-title":"Mol Cancer"},{"key":"key20180107223030_b25-or-31-06-2804","first-page":"1441","article-title":"Overexpression of insulin-like growth factor binding protein 3 in oral squamous cell carcinoma","volume":"20","author":"Zhong","year":"2008","journal-title":"Oncol Rep"},{"key":"key20180107223030_b26-or-31-06-2804","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.molimm.2007.01.022","article-title":"TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance","volume":"44","author":"He","year":"2007","journal-title":"Mol Immunol"},{"key":"key20180107223030_b27-or-31-06-2804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2009.08.010","article-title":"Toll-like receptor signaling in cell proliferation and survival","volume":"49","author":"Li","year":"2009","journal-title":"Cytokine"},{"key":"key20180107223030_b28-or-31-06-2804","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00262-008-0459-8","article-title":"Toll-like receptors expressed in tumor cells: targets for therapy","volume":"57","author":"Yu","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"key20180107223030_b29-or-31-06-2804","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0897.2006.00441.x","article-title":"Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway","volume":"57","author":"Chen","year":"2007","journal-title":"Am J Reprod Immunol"},{"key":"key20180107223030_b30-or-31-06-2804","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1189\/jlb.1209775","article-title":"Endogenous ligands of TLR2 and TLR4: agonists or assistants?","volume":"87","author":"Erridge","year":"2010","journal-title":"J Leukoc Biol"},{"key":"key20180107223030_b31-or-31-06-2804","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.intimp.2008.08.009","article-title":"Rapamycin reverses TLR4 signaling-triggered tumor apoptosis resistance by disrupting Akt-mediated Bcl-xL upregulation","volume":"8","author":"Sun","year":"2008","journal-title":"Int Immunopharmacol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2014.3134\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T22:40:03Z","timestamp":1515364803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2014.3134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,11]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,4,11]]},"published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.3892\/or.2014.3134"],"URL":"https:\/\/doi.org\/10.3892\/or.2014.3134","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,11]]}}}